What is KeyCorp's Estimate for Westlake Q1 Earnings?

Westlake Co. (NYSE:WLK - Free Report) - Stock analysts at KeyCorp issued their Q1 2025 earnings per share (EPS) estimates for shares of Westlake in a note issued to investors on Sunday, April 13th. KeyCorp analyst A. Yefremov forecasts that the specialty chemicals company will earn $0.42 per share for the quarter. The consensus estimate for Westlake's current full-year earnings is $6.48 per share. KeyCorp also issued estimates for Westlake's Q2 2025 earnings at $1.38 EPS, Q3 2025 earnings at $0.88 EPS, Q4 2025 earnings at $0.16 EPS and FY2025 earnings at $2.83 EPS.

Westlake (NYSE:WLK - Get Free Report) last announced its quarterly earnings data on Monday, February 24th. The specialty chemicals company reported $0.06 earnings per share for the quarter, missing analysts' consensus estimates of $1.04 by ($0.98). Westlake had a net margin of 0.81% and a return on equity of 6.93%. The business had revenue of $2.84 billion during the quarter, compared to analyst estimates of $3.01 billion. During the same quarter last year, the firm posted $0.72 EPS. The company's revenue for the quarter was up .6% on a year-over-year basis.

WLK has been the subject of several other research reports. Truist Financial reduced their target price on shares of Westlake from $155.00 to $132.00 and set a "buy" rating for the company in a research note on Monday, April 14th. Barclays lowered their price objective on Westlake from $175.00 to $135.00 and set an "overweight" rating on the stock in a report on Tuesday, February 25th. Royal Bank of Canada cut their target price on Westlake from $147.00 to $133.00 and set an "outperform" rating for the company in a research note on Wednesday, February 26th. JPMorgan Chase & Co. upgraded Westlake from an "underweight" rating to a "neutral" rating and decreased their price target for the company from $135.00 to $110.00 in a research note on Thursday, February 27th. Finally, Citigroup cut their price objective on Westlake from $130.00 to $116.00 and set a "buy" rating for the company in a research report on Friday, April 4th. Five analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, Westlake has a consensus rating of "Moderate Buy" and an average price target of $122.25.

Westlake Stock Performance

Westlake stock traded up $1.54 during midday trading on Wednesday, hitting $91.86. 603,314 shares of the company's stock were exchanged, compared to its average volume of 565,138. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.79. The stock has a market cap of $11.80 billion, a price-to-earnings ratio of 129.37, a price-to-earnings-growth ratio of 2.36 and a beta of 1.02. Westlake has a 12-month low of $81.41 and a 12-month high of $161.31. The firm's 50 day simple moving average is $102.62 and its 200 day simple moving average is $117.11.

Westlake Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 19th. Shareholders of record on Tuesday, March 4th were paid a $0.525 dividend. This represents a $2.10 dividend on an annualized basis and a yield of 2.29%. The ex-dividend date was Tuesday, March 4th. Westlake's payout ratio is 45.36%.

Institutional Trading of Westlake

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC boosted its position in shares of Westlake by 1.0% in the fourth quarter. Geode Capital Management LLC now owns 557,943 shares of the specialty chemicals company's stock worth $63,832,000 after acquiring an additional 5,297 shares during the last quarter. Rhumbline Advisers boosted its holdings in shares of Westlake by 4.4% in the 4th quarter. Rhumbline Advisers now owns 98,056 shares of the specialty chemicals company's stock valued at $11,242,000 after purchasing an additional 4,088 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Westlake by 5.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 236,354 shares of the specialty chemicals company's stock worth $27,098,000 after buying an additional 11,992 shares during the last quarter. Janney Montgomery Scott LLC boosted its holdings in Westlake by 27.5% in the fourth quarter. Janney Montgomery Scott LLC now owns 59,499 shares of the specialty chemicals company's stock valued at $6,822,000 after acquiring an additional 12,833 shares during the last quarter. Finally, Victory Capital Management Inc. grew its position in Westlake by 21.0% during the fourth quarter. Victory Capital Management Inc. now owns 3,313,847 shares of the specialty chemicals company's stock valued at $379,933,000 after acquiring an additional 574,068 shares during the period. Hedge funds and other institutional investors own 28.40% of the company's stock.

Westlake Company Profile

Westlake Corporation engages in the manufacture and marketing of performance and essential materials, and housing and infrastructure products in the United States, Canada, Germany, China, Mexico, Brazil, France, Italy, Taiwan, and internationally. The company operates through two segments: Performance and Essential Materials and Housing and Infrastructure Products.